Sitagliptin in Combination Oral Agent Therapy for Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2010
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.